I never imagined I would be writing this. My mum passed away, and I don’t yet have the words to describe the emptiness she’s left behind. She wasn’t just my mother — she was my best friend, my anchor, my reason for fighting, and the heart behind everything we built here. This community was created for her. She carried more than most people ever see. She lived with bipolar disorder. She carried childhood trauma. She endured a painful divorce, the loss of both her parents, a cancer diagnosis, the death of Pepper — our family boxer — and the loss of Albert, our family’s closest friend. All of this happened within the last seven years. And yet — she kept going. She walked at least 10,000 steps a day. She swam three times a week. She went to church every Sunday. She worked tirelessly on the house. She quit smoking after her diagnosis. She tried carnivore. She cut out sugar. And most importantly: She kept our family together. She fought. She cared. She loved. Even when depression weighed heavily on her will to live, she chose to fight — not because it was easy, but because she loved us. She fought for us when her mind told her to give up. That is courage. We were hopeful. So hopeful. She had just started the Astron Health protocol — only one week in — and we believed we had time. Previous scans had been relatively reassuring, showing stable, very slow-growing, localised disease in the peritoneum and a coeliac lymph node, with no organ spread. Her CRP was 4 — within the normal range. Then everything changed — fast. She developed sudden, severe gastrointestinal pain, vomiting, and diarrhoea. We rushed to the hospital. A CT scan showed ischemic colitis. A mouth swab also confirmed COVID. She was put on palliative care, given fluids and heparin. Her circulation improved. Lactate came down. Symptoms improved. Objectively, things were getting better. But the narrative never changed. Despite improving vitals, improving markers, and improving symptoms, they continued to insist on bowel necrosis — even when the evidence did not clearly support it. At the same time, her CRP (an inflammation marker) rose rapidly from 4 (normal) just weeks earlier, to 14 on admission, to 150 the following day, and eventually to 455 at its peak. She developed rising oxygen requirements, hypoxia, and what appeared to be a clear systemic inflammatory storm — yet COVID pneumonitis was repeatedly dismissed.

I wanted to share something important with you — not as medical advice, but as part of our learning journey together ❤️ This post is shared for transparency and education only, not to suggest or recommend anything medically. This protocol was designed privately for my mum by Astron Health and is shared here purely for learning and discussion within our community. ✅ Everyone’s biology, cancer type, treatments, and risks are different ✅ Always work alongside your medical team My mum’s current protocol was built/personalised using molecular testing from her blood, done through Astron Health, who work with Exacta360. This kind of testing doesn’t just look at cancer type. It looks at what pathways are active, what the cancer appears to rely on, and what biological signals are dominant. In simple terms — it doesn’t ask: “What cancer is this?” It asks: “What is this cancer doing?” That shift changes everything. ✅ What This Kind of Testing Looks At From a simple blood sample, the analysis can look at things like: • inflammation signaling • growth and survival pathways • angiogenesis (blood vessel formation) • immune suppression markers • estrogen and hormone metabolism • metabolic stress pathways • mitochondrial vulnerability It gives a much clearer picture of the terrain. ✅ Something That Really Stood Out to Me What surprised me most was this… Almost everything Astron included was already part of our existing protocol. The core metabolic approach we’ve been using aligned very closely with what the molecular testing came back with — thanks in huge part to this community, Dr. Seyfried, and Jane McLelland. They added a few additional layers — such as: • atorvastatin • indole-3-carbinol • luteolin • apigenin • ursolic acid • propranolol But the foundation was already there. That was incredibly validating — not just emotionally, but scientifically. It confirmed that targeting the right pathways truly matters. ✅ Compounds That Came Up in Her Results Some of the natural compounds included were:

To every one of you walking this path — whether you’re fighting, supporting someone you love, researching late at night, or simply trying to hold things together — I want you to know how deeply respected you are. This journey is not easy. It takes courage, resilience, curiosity, and heart. And yet, despite everything, this community continues to show up with generosity, wisdom, and care for one another. That matters more than words can express. Christmas can bring joy, but it can also bring reflection, uncertainty, and mixed emotions — and all of that is okay. Wherever you find yourself today, please know you’re not alone. Wishing you peace, moments of warmth, and renewed hope as we move toward a new year together 💚

Hey Warriors 🙂, I’ve been a bit quieter lately as we’ve been working behind the scenes on something important: My mum completed the Astron Health multi-omic analysis, and the results have finally arrived. Next week we meet Astron’s integrative oncologist to go through the full interpretation — but I want to share the key insights now, because this is something that can empower every person in this community. ⭐ What Astron Revealed About My Mum’s Cancer Her tumour is not random. It runs on specific biological pathways — almost like an engine with identifiable components. The major drivers they identified were: 🔥 FGFR2 → MAPK (Main Growth Engine) 🔥 VEGF / Angiogenesis (Blood Supply) 🔥 MMP15 (Invasion + Tissue Breakdown) 🔥 WNT Signalling (Stem-Cell Survival + Recurrence) 🔥 FANCA Mutation (DNA-Repair Weakness → ROS Sensitivity) And important update: ➡️ CTCs were only 2, which is very low and extremely reassuring. ⭐ This Report Was NOT Essential — But It Was Incredibly Helpful I want to make something clear to everyone: You do NOT need expensive molecular testing to build an effective, multi-pathway protocol. Over the past 1.5 years, I created my mum’s protocol by studying: - cancer signalling pathways - metabolic vulnerabilities - invasion markers - angiogenesis mechanisms - mitochondrial weaknesses - stem-cell biology And what shocked me was this: The Astron findings matched almost exactly what I had already built through research alone. This is HUGE for this community. It proves that: ✔ you can learn what drives your cancer ✔ you can build precision strategies without testing ✔ you can target the actual pathways behind the disease ✔ you do NOT need to shoot in the dark The report confirmed the work — it didn’t create it. ⭐ The One Pathway We Had Not Fully Targeted: RAS → MAPK Astron’s report highlighted one important component: Atorvastatin This inhibits RAS prenylation, which is the top upstream switch that activates the MAPK pathway — the main engine of her tumour.

Hey Warriors, I wanted to share an honest update about my mum’s latest scan and what I’ve learned through this process — I hope it helps others make more informed decisions. Unfortunately, my mum’s recent PET scan results weren’t good. For context, the previous scan in June showed a mixed response with one new lesion appearing. Because of financial constraints, we stopped IV Vitamin C and HBOT about four months ago, and I had planned to strengthen her protocol with additional off-label therapies — Low Dose Naltrexone (LDN), Doxycycline, Hydroxychloroquine, and Niclosamide — all discussed in Jane McLelland’s book How to Starve Cancer. My mum completed the 3-month Orthomolecular protocol back in June and that’s when we saw positive but mixed results. At the time, my mum had strong faith in the NHS oncologists and their plan with immunotherapy (Keytruda). They weren’t sure if the June scan reflected pseudoprogression or inflammation, and even though the radiologist advised a CT scan for clarification, the oncologists decided to wait until the next PET scan. Sadly, that delay cost us valuable time. The latest scan now shows more lesions, and we were told now that SRS/Gamma Knife is no longer an option. The oncologist’s words were: “It’s too late for that.” Also CA125 jumped from 395 to 1100 in 3/4 months. The NHS is an incredible resource in many ways, especially because it funds chemotherapy and immunotherapy, but most NHS doctors have little or no understanding of metabolic therapy. They tend to dismiss it or even speak negatively about it. I printed out research papers and handed them directly to the team, but they ignored them completely. My mum followed their advice because she trusted them, which is understandable, but this experience has changed her perspective. Now she wants to move forward under integrative expert guidance, possibly through Astron Health or a similar precision-medicine approach. From Jane McLelland’s book, I learned that adenocarcinomas (like my mum’s) are generally glutamine-driven, meaning they rely heavily on glutamine as a primary fuel source. We target glutamine in several ways — through fasting and exercise simultaneously, which deplete available fuel, and more importantly through the use of specific off-label drugs. One of the most powerful glutamine antagonists is DON (6-diazo-5-oxo-L-norleucine), though it’s out of reach for most of us due to limited access and high cost. That’s why it’s crucial to investigate or implement other off-labels that can impact glutamine metabolism indirectly. This is also where diet becomes strategic: a pescatarian approach, as Jane suggests, or a vegan keto diet during the kill phase makes a lot of sense for targeting both glutamine and methionine metabolism simultaneously.